SMITHA JOHN: Open Payments
NPI 1275050684 · CARMEL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,245 in 61 payments from 12 companies in 2025. Trend: 2023 $1,414 · 2024 $1,453 · 2025 $1,245
Food & beverage: $1,245
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $275 |
| GlaxoSmithKline, LLC. | 9 | $194 |
| Novo Nordisk Inc | 9 | $170 |
| PFIZER INC. | 13 | $167 |
| Lilly USA, LLC | 7 | $119 |
| Astellas Pharma US Inc | 4 | $94 |
| Exact Sciences Corporation | 3 | $71 |
| Phathom Pharmaceuticals, Inc. | 3 | $56 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
Products named: TRELEGY ELLIPTA, TEZSPIRE, Veozah, FARXIGA, Wegovy, MOUNJARO, ELIQUIS, Cologuard Collection Kit.
Industry payments across NY — which companies pay providers there.
